Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma
Authors:
- 1 June 2019
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 143 (6) , e20182495
Abstract
Cardiac rhabdomyoma is the most common neonatal cardiac tumor and is typically associated with tuberous sclerosis complex (TSC). Although these tumors may naturally regress, some patients require surgical resection because of cardiac instability. If not fully resected, patients may also require medical therapy to improve their hemodynamics. Everolimus, a mammalian target of rapamycin inhibitor, has shown promise in reducing rhabdomyoma in patients with TSC, but the drug’s impact in patients without TSC has not been reported. Monitoring of tumor response has typically been limited to echocardiograms, which is not ideal given inherent difficulties in three-dimensional measurements. We report a case of sporadic cardiac rhabdomyoma in a neonate treated with everolimus resulting in tumor regression as documented by cardiac MRI. While on everolimus, our patient had an increased incidence of a preexisting arrhythmia, which resolved with planned cessation of therapy, suggesting that close monitoring is imperative in patients with arrhythmia.Keywords
This publication has 25 references indexed in Scilit:
- Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmiaCardiology in the Young, 2014
- Regression of Symptomatic Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in a Newborn Receiving EverolimusJournal of Tropical Pediatrics, 2014
- Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimusUltrasound in Obstetrics & Gynecology, 2014
- Drug Interactions and the Pharmacist: Focus on EverolimusAnnals of Pharmacotherapy, 2013
- Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in 11 Children: Presentation to OutcomePediatric Hematology and Oncology, 2012
- Everolimus: A Challenging Drug in the Treatment of Multifocal Inoperable Cardiac RhabdomyomaPediatrics, 2012
- Regression of a Cardiac Rhabdomyoma in a Patient Receiving EverolimusPediatrics, 2011
- Cardiac Rhabdomyomas in Tuberous Sclerosis Complex Show Apoptosis Regulation and mTOR Pathway AbnormalitiesPediatric and Developmental Pathology, 2009
- Comparison of Echo and MRI in the Imaging Evaluation of Intracardiac MassesCardioVascular and Interventional Radiology, 2004
- Natural history of cardiac rhabdomyoma in infancy and childhoodThe American Journal of Cardiology, 1990